These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16019237)
21. Topiramate titration to response: analysis of individualized therapy study (TRAITS). Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932 [TBL] [Abstract][Full Text] [Related]
22. Topiramate monotherapy in epilepsy and migraine prevention. Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478 [TBL] [Abstract][Full Text] [Related]
23. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Ben-Menachem E; Henriksen O; Dam M; Mikkelsen M; Schmidt D; Reid S; Reife R; Kramer L; Pledger G; Karim R Epilepsia; 1996 Jun; 37(6):539-43. PubMed ID: 8641230 [TBL] [Abstract][Full Text] [Related]
24. Long-term safety and sustained efficacy of USL255 (topiramate extended-release capsules) in patients with refractory partial-onset seizures. Chung SS; Hogan RE; Blatt I; Lawson P B; Nguyen H; Clark AM; Anders B; Halvorsen MB; Epilepsy Behav; 2016 Jun; 59():13-20. PubMed ID: 27084978 [TBL] [Abstract][Full Text] [Related]
25. The effects of adjunctive topiramate therapy on seizure severity and health-related quality of life in patients with refractory epilepsy---a Canadian study. Baker GA; Currie NG; Light MJ; Schneiderman JH; Seizure; 2002 Jan; 11(1):6-15. PubMed ID: 11888254 [TBL] [Abstract][Full Text] [Related]
26. Exploring efficacy and tolerability outcomes in patients with difficult-to-treat epilepsy receiving adjunctive topiramate at different titration rates--an exploratory study. Kurth C; Schäuble B; Schreiner A; Rettig K; Steinhoff BJ Acta Neurol Scand; 2009 Aug; 120(2):80-7. PubMed ID: 19432934 [TBL] [Abstract][Full Text] [Related]
27. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice. Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F; Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of topiramate as adjunctive therapy in refractory partial seizures: United States trial experience. Faught E Epilepsia; 1997; 38 Suppl 1():S24-7. PubMed ID: 9092954 [TBL] [Abstract][Full Text] [Related]
30. A novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development. Sachdeo R; Partiot A; Biton V; Rosenfeld WE; Nohria V; Tompson D; DeRossett S; Porter RJ Int J Clin Pharmacol Ther; 2014 Jun; 52(6):509-18. PubMed ID: 24755135 [TBL] [Abstract][Full Text] [Related]
31. Clinical experience with open-label topiramate use in infants younger than 2 years of age. Watemberg N; Goldberg-Stern H; Ben-Zeev B; Berger I; Straussberg R; Kivity S; Kramer U; Brand N; Lerman-Sagie T J Child Neurol; 2003 Apr; 18(4):258-62. PubMed ID: 12760428 [TBL] [Abstract][Full Text] [Related]
32. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030 [TBL] [Abstract][Full Text] [Related]
33. Topiramate as an add-on antiepileptic drug in treating refractory canine idiopathic epilepsy. Kiviranta AM; Laitinen-Vapaavuori O; Hielm-Björkman A; Jokinen T J Small Anim Pract; 2013 Oct; 54(10):512-20. PubMed ID: 24032479 [TBL] [Abstract][Full Text] [Related]
34. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Majkowski J; Neto W; Wapenaar R; Van Oene J Epilepsia; 2005 May; 46(5):648-53. PubMed ID: 15857429 [TBL] [Abstract][Full Text] [Related]
35. The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: a multi-center clinical trial. Al Ajlouni S; Shorman A; Daoud AS Seizure; 2005 Oct; 14(7):459-63. PubMed ID: 16087357 [TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919 [TBL] [Abstract][Full Text] [Related]